Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

RISEDRONATE IMPURITY E CRS (15 MG)

RISEDRONATE IMPURITY E CRS (15 MG)

75755-10-1

DISCOVER
RISEDRONATE SODIUM 2.5- HYDRATE CRS (15 MG)

RISEDRONATE SODIUM 2.5- HYDRATE CRS (15 MG)

329003-65-8

DISCOVER
INSULIN GLARGINE CRS (15 MG)

INSULIN GLARGINE CRS (15 MG)

160337-95-1

DISCOVER
ACTAEA RACEMOSA FOR ASSAY CRS(300 MG)

ACTAEA RACEMOSA FOR ASSAY CRS(300 MG)

53956-04-0

DISCOVER
INSULIN GLARGINE FOR PEAK IDENTIFICATION CRS (3.2 MG)

INSULIN GLARGINE FOR PEAK IDENTIFICATION CRS (3.2 MG)

160337-95-1

DISCOVER
CHLORHEXIDINE FOR SYSTEM SUITABILITY CRS (15 MG)

CHLORHEXIDINE FOR SYSTEM SUITABILITY CRS (15 MG)

NA

DISCOVER
GONADORELIN FOR NMR IDENTIFICATION CRS (6 MG)

GONADORELIN FOR NMR IDENTIFICATION CRS (6 MG)

ND

DISCOVER
PROPYLENE GLYCOL CRS (150 MG)

PROPYLENE GLYCOL CRS (150 MG)

57-55-6

DISCOVER
LABETALOL IMPURITY A CRS (10 MG)

LABETALOL IMPURITY A CRS (10 MG)

NA

DISCOVER
OXCARBAZEPINE IMPURITY MIXTURE CRS (0.008 MG)

OXCARBAZEPINE IMPURITY MIXTURE CRS (0.008 MG)

NA

DISCOVER
POLY(VINYL ALCOHOL) CRS (100 MG)

POLY(VINYL ALCOHOL) CRS (100 MG)

9002-89-5

DISCOVER
ABACAVIR FOR SYSTEM SUITABILITY CRS (10 MG)

ABACAVIR FOR SYSTEM SUITABILITY CRS (10 MG)

188062-50-2

DISCOVER